Clinical Trial Update: Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia [Phase 3]

View source ↗

Summary

The Phase 3 trial assessing irbesartan for improving retinal endothelial function in adults with hypercholesterolemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Hypercholesterolemia | Phase 3 | Status: WITHDRAWN